Sensei Biotherapeutics to Acquire Faeth Therapeutics

Sensei Biotherapeutics has announced an acquisition of Faeth Therapeutics and a concurrent private placement. The deal is structured as a merger and is paired with $200 million of new private financing.

The provided material does not include deal consideration details for the acquisition portion, but it confirms the $200 million concurrent private placement amount tied to the transaction.